You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
聖達生物(603079.SH)與關聯方銀輪股份共同對銀康生物進行投資
格隆匯 01-03 16:07

格隆匯1月3日丨聖達生物(603079.SH)公佈,公司、姑蘇(廣州)投資合夥企業(有限合夥)(“姑蘇投資”)及公司關聯方浙江銀輪機械股份有限公司(“銀輪股份”)分別以1020萬元、1020萬元、3060萬元認購天台銀康生物醫藥有限公司(“銀康生物”或“被投資方”)500萬元、500萬元、1500萬元註冊資本;交易完成後,銀康生物註冊資本將由4902.50萬元變更為7402.50萬元。

公司與關聯方銀輪股份共同對銀康生物進行投資,根據《上海證券交易所股票上市規則》、《上海證券交易所上市公司關聯交易實施指引》的規定,此次交易構成關聯交易。

公司參股銀康生物有利於公司大健康戰略的順利推進,進一步豐富公司的產業結構,有利於公司的長遠發展,為公司及股東創造更高的價值。

由於銀康生物在研項目目前正處於臨牀試驗階段,能否順利通過臨牀試驗、能否能取得藥品生產許可證存在一定風險。在項目開發過程中,存在一定的管理風險、資金風險、開發進度風險以及產品更新迭代的風險等潛在風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account